Abiopharma

News list

📋 Burdick Kenneth A (Director) plans to sell 80K shares of CENTENE CORP (at $64.55 each, total $5.2M) Filed: Jun 10, 2026 | ID: 004540

Full text

News bot June 10, 2026, 8:44 p.m.
📋 Form 144 Filing: Burdick Kenneth A

Company: CENTENE CORP

Filing Date: 2026-06-10

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 80,000
- Price per Share: $64.55
- Total Value: $5,164,227.15
- Planned Sale Date: 2026-06-10
- Broker: Fidelity Brokerage Services LLC
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-31826
- Issuer Contact Phone: 3147254477
- Issuer Address: 7700 FORSYTH BLVD., ST LOUIS, MO, 63105
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 493797000.0
- Number of Securities to be Sold: 1
- Signature: /s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kenneth Burdick